Pyrazinamide
PYRAZINAMIDE TABLETS USP, 500 mg
Approved
Approval ID
2b5aef5f-d966-55e0-e054-00144ff8d46c
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Feb 9, 2016
Manufacturers
FDA
Department of State Health Services, Pharmacy Branch
DUNS: 781992540
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Pyrazinamide
PRODUCT DETAILS
NDC Product Code55695-026
Application NumberANDA081319
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateFebruary 9, 2016
Generic NamePyrazinamide
INGREDIENTS (6)
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
CALCIUM PHOSPHATE, DIBASIC, DIHYDRATEInactive
Code: O7TSZ97GEP
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT
PYRAZINAMIDEActive
Quantity: 500 mg in 1 1
Code: 2KNI5N06TI
Classification: ACTIB